1H-Pyrazolo[3,4-c]pyridine, 3-bromo-5-chloro-1-methyl-
|
H678011-500mg
|
≥97% |
1784838-79-4 |
500mg
|
¥ 2240.9
|
期货,请咨询 |
阿拉丁 |
1H-Pyrazolo[3,4-c]pyridine, 3-bromo-5-chloro-1-methyl-
|
H678011-25g
|
≥97% |
1784838-79-4 |
25g
|
¥ 36320.9
|
期货,请咨询 |
阿拉丁 |
1H-Pyrazolo[3,4-c]pyridine, 3-bromo-5-chloro-1-methyl-
|
H678011-250mg
|
≥97% |
1784838-79-4 |
250mg
|
¥ 1568.9
|
期货,请咨询 |
阿拉丁 |
1H-Pyrazolo[3,4-c]pyridine, 3-bromo-5-chloro-1-methyl-
|
H678011-1g
|
≥97% |
1784838-79-4 |
1g
|
¥ 3200.9
|
期货,请咨询 |
阿拉丁 |
1H-Pyrazolo[3,4-c]pyridine, 3-bromo-5-chloro-1-methyl-
|
H678011-10g
|
≥97% |
1784838-79-4 |
10g
|
¥ 16512.9
|
期货,请咨询 |
阿拉丁 |
1H-Pyrazolo[3,4-c]pyridine, 3-bromo-5-chloro-1-methyl-
|
H678011-100mg
|
≥97% |
1784838-79-4 |
100mg
|
¥ 944.9
|
期货,请咨询 |
阿拉丁 |
1H-Indazole, 5-bromo-3-methyl-1-(tetrahydro-2H-pyran-2-yl)-
|
H678010-5g
|
≥97% |
1777783-11-5 |
5g
|
¥ 88320.9
|
期货,请咨询 |
阿拉丁 |
1H-Indazole, 5-bromo-3-methyl-1-(tetrahydro-2H-pyran-2-yl)-
|
H678010-500mg
|
≥97% |
1777783-11-5 |
500mg
|
¥ 19632.9
|
期货,请咨询 |
阿拉丁 |
1H-Indazole, 5-bromo-3-methyl-1-(tetrahydro-2H-pyran-2-yl)-
|
H678010-250mg
|
≥97% |
1777783-11-5 |
250mg
|
¥ 11776.9
|
期货,请咨询 |
阿拉丁 |
1H-Indazole, 5-bromo-3-methyl-1-(tetrahydro-2H-pyran-2-yl)-
|
H678010-1g
|
≥97% |
1777783-11-5 |
1g
|
¥ 29440.9
|
期货,请咨询 |
阿拉丁 |
1H-Indazole, 5-bromo-3-methyl-1-(tetrahydro-2H-pyran-2-yl)-
|
H678010-100mg
|
≥97% |
1777783-11-5 |
100mg
|
¥ 7072.9
|
期货,请咨询 |
阿拉丁 |
(3R,4S)-3-hydroxypiperidine-4-carbonitrile;hydrochloride
|
H677916-5g
|
≥97% |
N/A |
5g
|
¥ 76000.9
|
期货,请咨询 |
阿拉丁 |
(3R,4S)-3-hydroxypiperidine-4-carbonitrile;hydrochloride
|
H677916-500mg
|
≥97% |
N/A |
500mg
|
¥ 14000.9
|
期货,请咨询 |
阿拉丁 |
(3R,4S)-3-hydroxypiperidine-4-carbonitrile;hydrochloride
|
H677916-250mg
|
≥97% |
N/A |
250mg
|
¥ 9808.9
|
期货,请咨询 |
阿拉丁 |
(3R,4S)-3-hydroxypiperidine-4-carbonitrile;hydrochloride
|
H677916-1g
|
≥97% |
N/A |
1g
|
¥ 20000.9
|
期货,请咨询 |
阿拉丁 |
(3R,4S)-3-hydroxypiperidine-4-carbonitrile;hydrochloride
|
H677916-100mg
|
≥97% |
N/A |
100mg
|
¥ 5888.9
|
期货,请咨询 |
阿拉丁 |
[(1R,3S,5R)-5-methyl-2-azabicyclo[3.1.0]hexan-3-yl]methanol;hydrochloride
|
H677850-5g
|
≥97% |
2920233-12-9 |
5g
|
¥ 95040.9
|
期货,请咨询 |
阿拉丁 |
[(1R,3S,5R)-5-methyl-2-azabicyclo[3.1.0]hexan-3-yl]methanol;hydrochloride
|
H677850-500mg
|
≥97% |
2920233-12-9 |
500mg
|
¥ 21120.9
|
期货,请咨询 |
阿拉丁 |
[(1R,3S,5R)-5-methyl-2-azabicyclo[3.1.0]hexan-3-yl]methanol;hydrochloride
|
H677850-250mg
|
≥97% |
2920233-12-9 |
250mg
|
¥ 12672.9
|
期货,请咨询 |
阿拉丁 |
[(1R,3S,5R)-5-methyl-2-azabicyclo[3.1.0]hexan-3-yl]methanol;hydrochloride
|
H677850-1g
|
≥97% |
2920233-12-9 |
1g
|
¥ 31680.9
|
期货,请咨询 |
阿拉丁 |
[(1R,3S,5R)-5-methyl-2-azabicyclo[3.1.0]hexan-3-yl]methanol;hydrochloride
|
H677850-100mg
|
≥97% |
2920233-12-9 |
100mg
|
¥ 7920.9
|
期货,请咨询 |
阿拉丁 |
5-[diethoxyphosphoryl(difluoro)methyl]-1H-indole-2-carboxylic acid
|
H677847-5g
|
≥97% |
1233086-50-4 |
5g
|
¥ 86544.9
|
期货,请咨询 |
阿拉丁 |
5-[diethoxyphosphoryl(difluoro)methyl]-1H-indole-2-carboxylic acid
|
H677847-500mg
|
≥97% |
1233086-50-4 |
500mg
|
¥ 19328.9
|
期货,请咨询 |
阿拉丁 |
5-[diethoxyphosphoryl(difluoro)methyl]-1H-indole-2-carboxylic acid
|
H677847-250mg
|
≥97% |
1233086-50-4 |
250mg
|
¥ 13520.9
|
期货,请咨询 |
阿拉丁 |